These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 14563186

  • 1. Role of faecal calprotectin as non-invasive marker of intestinal inflammation.
    Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Sterpi C, Marchi S, Maltinti G.
    Dig Liver Dis; 2003 Sep; 35(9):642-7. PubMed ID: 14563186
    [Abstract] [Full Text] [Related]

  • 2. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.
    Arq Gastroenterol; 2015 Sep; 52(1):50-4. PubMed ID: 26017083
    [Abstract] [Full Text] [Related]

  • 3. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH, Chou JW, Chen SM, Tsai MC, Sun YS, Lin CC, Lin CP.
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [Abstract] [Full Text] [Related]

  • 4. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A.
    Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
    [Abstract] [Full Text] [Related]

  • 5. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [Abstract] [Full Text] [Related]

  • 6. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N, Cummins E, Royle P, Kandala NB, Shyangdan D, Arasaradnam R, Clar C, Johnston R.
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [Abstract] [Full Text] [Related]

  • 7. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 8. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M.
    Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
    [Abstract] [Full Text] [Related]

  • 9. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
    Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):615-21. PubMed ID: 15352909
    [Abstract] [Full Text] [Related]

  • 11. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M, Trouvé C, Baert F, De Smet D, Langlois M, Vanpoucke H.
    Clin Chem Lab Med; 2014 Mar 15; 52(3):391-7. PubMed ID: 24114912
    [Abstract] [Full Text] [Related]

  • 12. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Summerton CB, Longlands MG, Wiener K, Shreeve DR.
    Eur J Gastroenterol Hepatol; 2002 Aug 15; 14(8):841-5. PubMed ID: 12172403
    [Abstract] [Full Text] [Related]

  • 13. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ, Sydora BC, Fedorak RN.
    J Crohns Colitis; 2012 Mar 15; 6(2):207-14. PubMed ID: 22325175
    [Abstract] [Full Text] [Related]

  • 14. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.
    Aliment Pharmacol Ther; 2016 May 15; 43(10):1069-79. PubMed ID: 26953251
    [Abstract] [Full Text] [Related]

  • 15. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
    Theede K, Kiszka-Kanowitz M, Nordgaard-Lassen I, Nielsen AM.
    Ugeskr Laeger; 2014 Sep 08; 176(37):. PubMed ID: 25294035
    [Abstract] [Full Text] [Related]

  • 16. What is the faecal calprotectin test?
    Drug Ther Bull; 2014 Sep 08; 52(9):102-4. PubMed ID: 25213590
    [Abstract] [Full Text] [Related]

  • 17. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP, McNicholl AG.
    Dig Liver Dis; 2009 Jan 08; 41(1):56-66. PubMed ID: 18602356
    [Abstract] [Full Text] [Related]

  • 18. Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation.
    Fu Y, Wang L, Xie C, Zou K, Tu L, Yan W, Hou X.
    Sci Rep; 2017 Jun 01; 7(1):2669. PubMed ID: 28572616
    [Abstract] [Full Text] [Related]

  • 19. Fecal calprotectin as a promising marker of inflammatory diseases.
    Paduchova Z, Durackova Z.
    Bratisl Lek Listy; 2009 Jun 01; 110(10):598-602. PubMed ID: 20017448
    [Abstract] [Full Text] [Related]

  • 20. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov 01; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.